TLRY - Conference and earnings call announcements

NEW YORK and LEAMINGTON, Ontario, April 15, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced a series of strategic initiatives marking its next phase of global growth, expanding its leadership across healthcare, cannabis and beverage while strengthening its ability to expand internationally and capture emerging market opportunities. Irwin D. Simon, Chairman and Chief Executive Officer, Tilray Brands, stated: "Tilray Brands is setting the pace for global innovation across healthcare, cannabi

Operational Efficiencies and Focus on Profitability Drove Net Income of $1.5 Million, Adjusted EBITDA Increased 9% to $10 Million and Net Cash Used in Operations Improved by $34 Million Year-Over-Year Canadian Adult-Use Cannabis Gross Revenue Increased 12%, Maintaining the #1 Position in Revenue and Expanding Market Share; International Cannabis Revenue Grew 10% Year-Over-Year Balance Sheet Strengthened to $265 Million in Cash; Net Debt Reduced to $4 Million Reiterates Fiscal Year 2026 Adjusted EBITDA Outlook of $62 Million – $72 Million NEW YORK and LONDON and LEAMINGTON, Ontario, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TL

NEW YORK and LEAMINGTON, Ontario, May 29, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced that Irwin D. Simon, Chairman and Chief Executive Officer, and Carl Merton, Chief Financial Officer, will participate in a fireside chat and host one-on-one meetings at the TD Cowen 9th Annual Future of the Consumer Conference on June 3, 2025, in New York, NY. The fireside chat is scheduled for 11:00 a.m. ET and a webcast will be available on Events & Presentations section of Tilray's Investor Relations website. To schedule a one-o

Equity Insider News Commentary Issued on behalf of Safety Shot, Inc. VANCOUVER, B.C., May 20, 2025 /PRNewswire/ -- Equity Insider News Commentary – In the U.S. and abroad, analysts report that consumer interest in "boosted" drinks—those promising anything from gut health to stress relief—is not only rising but redefining how wellness is consumed. RBC's Nik Modi recently told an industry forum that functionality and wellness will dominate beverage growth over the next decade, driven by aging populations and rising demand for convenience. Meanwhile, according to Research and Markets the global market is forecast to swell to nearly $175 billion by 2030, with women and APAC consumers leading the

NEW YORK and LEAMINGTON, Ontario, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today announced a special meeting of stockholders (the "Special Meeting") on June 10, 2025. The Special Meeting will be held via live audio webcast, which can be accessed on the investor page on Tilray.com. At the Special Meeting, stockholders will be asked to vote for an amendment of the Company's Fifth Amended and Restated Certificate of Incorporation, in order to implement a reverse stock split of the Company's common stock at a rati

NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company, is pleased to announce a series of game day events at its craft breweries nationwide, featuring premium craft brews paired with specially curated wing offerings designed specifically for game day fans. Participating breweries include SweetWater Brewing Co., Montauk Brewing Co., Breckenridge Brewery, Blue Point Brewing Co., 10 Barrel Brewing Co., Hop Valley Brewing Co., Redhook Brewing Co., Terrapin Beer Co., and Atwater Brewery. Each one of Tilray's craft breweries is dedicated to providing fans with an exceptional experience for the BI

NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY) Chairman and Chief Executive Officer Irwin D. Simon will participate in a fireside chat at the Bernstein 39th Annual Strategic Decisions Conference on Thursday, June 1, 2023, in New York City beginning at 11:00 am Eastern Time. The fireside chat will be hosted by Nadine Sarwat, Director & Analyst, European & American Alcoholic Beverages, North America Cannabis.   Tilray's Chief Financial Officer Carl Merton will also be meeting with institutional investors throughout the day. Please contact your Bernstein representative to schedule a meeting. About Tilray Brands Tilray Brands, Inc. (NASDAQ:

Tilray Expands and Strengthens U.S. Footprint with Acquisition of the Fastest Growing Craft Beer Brand and #1 Craft Brewer in Metro New York1 Montauk Brewing Deal Expected to be Accretive, Deliver Strong Revenue and Adjusted EBITDA, and Accelerate the Expansion of Tilray's Powerful U.S. Brand Portfolio Veteran Industry Executive Ty H. Gilmore Appointed President of Tilray Brands' U.S. Beer Business NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ( "Tilray Brands" or the "Company") ((NASDAQ, TSX:TLRY), today announced the acquisition of Montauk Brewing Company ("Montauk Brewing"), the #1 craft brewer in Metro New York. Montauk Brewing is well-known for its beloved p

NEW YORK, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Tilray, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, announced that the Company will participate in two Jefferies investor conferences. On Tuesday, November 16, 2021, the Company will participate in the Jefferies Virtual West Coast Consumer Conference. The fireside chat will begin at 2:00 PM ET.On Wednesday, November 17, 2021, the Company will participate in the Jefferies London Healthcare Conference. The fireside chat will begin at 11:20 AM ET. Please refer to the Investors section of the Company's website at www.Tilray.com under "Events and Presentations" for webcas

Tilray, Inc. ("Tilray") ((NASDAQ, TSX:TLRY) a leading global cannabis-lifestyle and consumer packaged goods company, announced today that Irwin D Simon, Chairman and Chief Executive Officer, Tilray, and Carl Merton, Chief Financial Officer, Tilray, will participate in the Barclays Global Consumer Staples Conference on Friday, September 10, 2021 at 10:00 a.m. Eastern Time. The live audio webcast will be accessible in the Events & Presentation section on the Company's Investor Relations website at https://ir.tilray.com/events-and-presentations/events. An archived replay of the webcast will also be available shortly after the live event has concluded. About Tilray Tilray, Inc. is a leading

Votes already cast point to support for both the Authorized Shares Proposal and the Governance Proposals Tilray urges stockholders to vote immediately in support of long-term value creation Tilray, Inc. ("Tilray" or the "Company") ((NASDAQ, TSX:TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today convened and then adjourned the Special Meeting of Stockholders intended to approve two shareholder proposals: (1) a proposal to increase the authorized number of shares of common stock ("Authorized Shares Proposal"); and (2) a number of governance enhancements to increase stockholder rights (the "Governance Proposals"). The Special Meeting was adjourned to Septem

Preliminary assessment of votes already cast points to overwhelming support for both the Authorized Shares Proposal and the Governance Proposals Tilray urges stockholders to vote immediately in support of long-term value creation Tilray, Inc. ("Tilray" or the "Company") ((NASDAQ, TSX:TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today convened and then adjourned the Special Meeting of Stockholders intended to approve two shareholder proposals: (1) a proposal to increase the authorized number of shares of common stock ("Authorized Shares Proposal"); and (2) a number of governance enhancements to increase stockholder rights (the "Governance Proposals"). The

Tilray, Inc. ("Tilray") ((NASDAQ, TSX:TLRY) announced that the Company will participate in the BMO Capital Markets 16th Annual Farm to Market Conference on Wednesday, May 19, 2021. The presentation will begin at 8:40 AM ET. Please refer to the Investors section of the Company's website at www.tilray.com under "Events and Presentations" for webcast information. About Tilray Tilray, Inc. is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people's lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best

NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced both Institutional Shareholder Services Inc. (“ISS”) and Glass Lewis and Co., LLC (“Glass Lewis”) have recommended that holders (the “Shareholders”) of Tilray common shares (the “Shares”) vote FOR the proposals to complete the business combination between Aphria Inc. and Tilray (the “Transaction”). ISS and Glass Lewis are the world’s leading independent proxy advisory firms that provide voting recommendations to institutional shareholders. Tilray Shareholders who held Shares as of the March 12, 2021 record date are

NANAIMO, British Columbia & PARIS--(BUSINESS WIRE)--Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis production, research, cultivation, and distribution, announced that it has been selected by the French National Agency for the Safety of Medicines and Health Products (ANSM) to supply Good Manufacturing Processes (GMP) certified medical cannabis products for experimentation in France. Tilray will supply GMP-produced medical cannabis products to serve patients in need for the duration of the French experiment (18-24 months), due to begin in the first quarter of 2021. Tilray products will be administered to qualifying patients in the French experiment, for whom existing tre